The current financial score of Genprex Inc is 6.82. Its financial status is robust, and its operating efficiency is low.
The current valuation score of Genprex Inc is 9.08. Its current P/E ratio is -0.70, which is -2038.33% below the recent high of 13.57 and -413.47% above the recent low of -3.60.
No earnings forecast score is currently available for Genprex Inc. The Biotechnology & Medical Research industry's average is 8.11.
The current price momentum score of Genprex Inc is 4.49. Currently, the stock price is trading between the resistance level at 4.05 and the support level at 3.14, making it suitable for range-bound swing trading.
The current institutional shareholding score of Genprex Inc is 3.00. The latest institutional shareholding proportion is 0.63%, representing a quarter-over-quarter decrease of 26.05%.
No risk assessment score is currently available for Genprex Inc. The Biotechnology & Medical Research industry's average is 3.97. The company's beta value is -0.96. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.